Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 29;10(1):30-38.
doi: 10.32481/djph.2024.03.06. eCollection 2024 Mar.

Community Partnership to Co-Develop an Intervention to Promote Equitable Uptake of the COVID-19 Vaccine Among Pediatric Populations

Paul T Enlow  1 , Courtney Thomas  2 , Angel Munoz Osorio  2 , Marshala Lee  3 , Jonathan M Miller  4 , Lavisha Pelaez  5 , Anne E Kazak  1 , Thao-Ly T Phan  1
Affiliations

Community Partnership to Co-Develop an Intervention to Promote Equitable Uptake of the COVID-19 Vaccine Among Pediatric Populations

Paul T Enlow et al. Dela J Public Health. .

Abstract

Objective: To describe the process of engaging community, caregiver, and youth partners in codeveloping an intervention to promote equitable uptake of the COVID-19 vaccine in non-Hispanic Black (Black) and Hispanic youth who experience higher rates of COVID-19 transmission, morbidity, and mortality but were less likely to receive the COVID-19 vaccine.

Methods: A team of 11 Black and Hispanic community partners was assembled to codevelop intervention strategies with our interdisciplinary research team. We used a mixed-methods crowdsourcing approach with Black and Hispanic youth (n=15) and caregivers of Black and Hispanic youth (n=20) who had not yet been vaccinated against COVID-19, recruited from primary care clinics, to elicit perspectives on the acceptability of these intervention strategies.

Results: We codeveloped five strategies: (1) community-tailored handouts and posters, (2) videos featuring local youth, (3) family-centered language to offer vaccines in the primary care clinic, (4) communication-skills training for primary care providers, and (5) use of community health workers to counsel families about the vaccine. The majority (56-96.9%) of youth and caregivers rated each of these strategies as acceptable, especially because they addressed common concerns and facilitated shared decision-making.

Conclusions: Engaging community and family partners led to the co-development of culturally- and locally-tailored strategies to promote dialogue and shared decision-making about the COVID-19 vaccine. This process can be used to codevelop interventions to address other forms of public health disparities.

Policy implications: Intervention strategies that promote dialogues with trusted healthcare providers and support shared decision-making are acceptable strategies to promote COVID-19 vaccine uptake among youth from historically underserved communities. Stakeholder-engaged methods may also help in the development of interventions to address other forms of health disparities.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Process for Co-Developing Intervention
See this image and copyright information in PMC

References

    1. Azar, K. M. J., Shen, Z., Romanelli, R. J., Lockhart, S. H., Smits, K., Robinson, S., et al. Pressman, A. R. (2020). Disparities in outcomes among COVID-19 patients in a large health care system in California: Study estimates the COVID-19 infection fatality rate at the US county level. Health Affairs (Project Hope), 39(7), 1253–1262. 10.1377/hlthaff.2020.00598 - DOI - PubMed
    1. Shi, D. S., Whitaker, M., Marks, K. J., Anglin, O., Milucky, J., Patel, K., et al. Havers, F. P. (2022, April 22). Hospitalizations of children aged 5-11 years with laboratory-confirmed COVID-19 - COVID-NET, 14 states, March 2020-February 2022. MMWR. Morbidity and Mortality Weekly Report, 71(16), 574–581. 10.15585/mmwr.mm7116e1 - DOI - PMC - PubMed
    1. Walter, E. B., Talaat, K. R., Sabharwal, C., Gurtman, A., Lockhart, S., Paulsen, G. C., et al. Gruber, W. C. (2022, January 6). Evaluation of the BNT162b2 Covid-19 vaccine in children 5 to 11 years of age. The New England Journal of Medicine, 386(1), 35–46. 10.1056/NEJMoa2116298 - DOI - PMC - PubMed
    1. Frenck, R. W., Jr., Klein, N. P., Kitchin, N., Gurtman, A., Absalon, J., Lockhart, S., et al. Gruber, W. C. (2021, July 15). Safety, immunogenicity, and efficacy of the BNT162b2 Covid-19 vaccine in adolescents. The New England Journal of Medicine, 385(3), 239–250. 10.1056/NEJMoa2107456 - DOI - PMC - PubMed
    1. Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., et al. Gruber, W. C. (2020, December 31). Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. The New England Journal of Medicine, 383(27), 2603–2615. 10.1056/NEJMoa2034577 - DOI - PMC - PubMed

LinkOut - more resources